Mark Christopher Capone, Chief Operating Officer, MGL at MYRIAD GENETICS INC (MYGN), sold 4,773 shares at $43.06 ($205K) on 2007-08-07, disclosed to the SEC on 2007-08-09.
Scheduled sale ($205k) by Chief Operating Officer, MGL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.00 | 4,073 | $175K | 85.3% |
| 2 | $43.01 | 200 | $9K | 4.2% |
| 3 | $43.03 | 100 | $4K | 2.1% |
| 4 | $43.04 | 100 | $4K | 2.1% |
| 5 | $43.06 | 100 | $4K | 2.1% |
| 6 | $43.07 | 200 |
| $9K |
| 4.2% |
| Total | $43.01 avg | 4,773 | $205K | 100% |
| Filing → |
| MYGN | SELL | 2018-07-13 | $3.3M | — | Filing → |
| MYGN | SELL | 2018-06-01 | $3.4M | — | Filing → |
| MYGN | BUY | 2016-08-19 | $425K | — | Filing → |